Top Markets
Coin of the day
Advicenne S.A. Advicenne S.A.

Advicenne S.A.

ALDVI
Clasificación en acciones #28004
Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the... Advicenne S.A. operates as a specialized pharmaceutical firm, focusing on the innovation and commercialization of therapeutic solutions for various kidney-related disorders. The company's primary offering, Sibnayal, targets both distal renal tubular acidosis and cystinuria. Established in 2007, Advicenne S.A. maintains its principal offices in Paris, France.
Precio por acción
$2.00
Última sincronización: 2026-08-19
Capitalización bursátil
$29.13M
Cambio (1 día)
0.24%
Cambio (1 año)
38.57%
País
FR
Comercio Advicenne S.A. (ALDVI)

Categoría

Ganancias de Advicenne S.A. (ALDVI)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Advicenne S.A., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Advicenne S.A. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -
US
$-3.09B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH